Skip to content

DYNAMIC PHARMA

Active
Public limited companyfounded 201015 yrs activeRue de l'Abattoir 1, 6700 Arlon, BelgiumKBO/BCE: BE 0831.334.045
Summary

DYNAMIC PHARMA has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€43,571) and a net result of €45,384. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 10% of 4231 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability73▲+20
Solvency22▲+2
Growth63=
Track record100
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity tight (current ratio 1.25 against 1.1 in 2024; short-term debt: 28.5% and cash: 2.1% of total assets), and equity is negative.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 15 years 0 20 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 10% of 4231 sector peers (2025).
NBB · sector comparison
Position among 4231 sector peers
Solvency
better than 10%
← weakest strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-08-2026, 20 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
20 d late
2024
72 d early
2023
19 d late
2022
6 d early
2021
17 d late
2020
30 d early
2019
28 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 3 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 17 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

DYNAMIC PHARMA was incorporated on 24 November 2010.1 Total assets fell from EUR 2.5 million in 2018 to EUR 1.4 million in 2025 and headcount from 9.6 to 8.5 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
€3.0m▲ 0.6%
2018 · €3.0m
EBIT margin
4.7%▲ 10.8pp
2018 · -6.1%
Net result
€45,384
2024 · -€5,134
Working capital
€100,403▲ 67.7%
2024 · €59,882
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Turnover
Operating result€230,849▲ 289%€75,492▼ 67.3%-€156,874€20,356€69,094▲ 239%
Net result€167,434above the sector's middle half▲ 529%€31,563within the sector's middle half▼ 81.1%-€185,233below the sector's middle half-€5,134below the sector's middle half▲ 97.2%€45,384within the sector's middle half
EBIT margin
Equity€69,849within the sector's middle half€101,412within the sector's middle half▲ 45.2%-€83,821below the sector's middle half-€88,955below the sector's middle half▼ 6.1%-€43,571below the sector's middle half▲ 51.0%
Total assets€2.4mabove the sector's middle half▼ 1.1%€2.1mwithin the sector's middle half▼ 12.6%€1.9mwithin the sector's middle half▼ 10.4%€1.6mwithin the sector's middle half▼ 12.9%€1.4mwithin the sector's middle half▼ 12.7%
Debt€2.3m▼ 6.8%€2.0m▼ 14.3%€2.0m▼ 1.6%€1.7m▼ 12.1%€1.5m▼ 14.7%
Working capital€509,880above the sector's middle half▲ 70.7%€398,180within the sector's middle half▼ 21.9%€138,228within the sector's middle half▼ 65.3%€59,882within the sector's middle half▼ 56.7%€100,403within the sector's middle half▲ 67.7%
Solvency2.9%below the sector's middle half▲ 5.9pp4.8%below the sector's middle half▲ 1.9pp-4.5%below the sector's middle half▼ 9.3pp-5.4%below the sector's middle half▼ 1.0pp-3.1%below the sector's middle half▲ 2.4pp
Current ratio1.67within the sector's middle half▲ 0.361.70within the sector's middle half▲ 0.031.20within the sector's middle half▼ 0.491.10within the sector's middle half▼ 0.101.25within the sector's middle half▲ 0.15
Return on assets (ROA)7.0%within the sector's middle half▲ 5.9pp1.5%within the sector's middle half▼ 5.5pp-9.9%below the sector's middle half▼ 11.4pp-0.3%within the sector's middle half▲ 9.6pp3.2%within the sector's middle half▲ 3.5pp
Staff (FTE)10within the sector's middle half=10.7within the sector's middle half▲ 7.0%10.7within the sector's middle half=9.7within the sector's middle half▼ 9.3%8.5within the sector's middle half▼ 12.4%
above within below the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
-€200,000€0€200,000Operating result 2021: €230,849€230,849Net result 2021: €167,434€167,434Operating result 2022: €75,492€75,492Net result 2022: €31,563€31,563Operating result 2023: -€156,874-€156,874Net result 2023: -€185,233-€185,233Operating result 2024: €20,356€20,356Net result 2024: -€5,134-€5,134Operating result 2025: €69,094€69,094Net result 2025: €45,384€45,38420212022202320242025-€200,000-€100,000€0€100,000Operating result 2023: -€156,874-€157,000Net result 2023: -€185,233-€185,000Operating result 2024: €20,356€20,400Net result 2024: -€5,134-€5,130Operating result 2025: €69,094€69,100Net result 2025: €45,384€45,400202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 239% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.4m
Fixed assets €918,899 ▼ 6.5%
Current assets €506,180 ▼ 22.1%
Key figures and ratios
2025 value · change against 2024
EBITDA
€150,192▲
2024 · €104,192
Cash flow
€126,482▲
2024 · €78,702
Quick ratio
0.55▼
2024 · 0.65
Debt to equity
-33.71▼
2024 · -19.36
Interest coverage
6.41▲
2024 · 4.14
Debt ≤ 1 year
€405,777▼
2024 · €590,212
Debt > 1 year
€1.0m▼
2024 · €1.1m
Income taxes
€270▼
2024 · €733
Staff costs
€600,087▼
2024 · €695,746
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 1,379 companies that looked in July 2024 the way this one looks now, 2.4% went bankrupt within 24 months and 94% are still going.

  • Micro
  • 10 to 20 years old
  • negative equity
  • a profit under 5% of the balance sheet
2.4% went bankrupt
3.2% stopped otherwise
94% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.6% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.9%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 1,379 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 56 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.6m€1.4m▼
Fixed assets21/28€983,061€918,899▼
Intangible fixed assets21€26€0▼
Tangible fixed assets22/27€979,263€915,058▼
Land and buildings22€931,777€871,252▼
Plant, machinery and equipment23€44,202€38,565▼
Furniture and vehicles24€3,284€5,242▲
Financial fixed assets28€3,772€3,841▲
Current assets29/58€650,095€506,180▼
Stocks and contracts in progress3€264,787€281,923▲
Stocks30/36€264,787€281,923▲
Amounts receivable within one year40/41€335,338€179,836▼
Trade receivables40€150,269€137,023▼
Other amounts receivable41€185,068€42,812▼
Cash at bank and in hand54/58€35,031€29,994▼
Deferred charges and accrued income490/1€14,939€14,427▼
Equity and liabilities
Total equity and liabilities10/49€1.6m€1.4m▼
Equity10/15-€88,955-€43,571▲
Contributions10/11€65,000€65,000=
Capital10€65,000€65,000=
Issued capital100€65,000€65,000=
Reserves13€6,500€6,500=
Non-distributable reserves130/1€6,500€6,500=
Legal reserve130€6,500€6,500=
Profit (loss) carried forward14-€160,455-€115,071▲
Amounts payable17/49€1.7m€1.5m▼
Amounts payable after more than one year17€1.1m€1.0m▼
Financial debts170/4€155,219€87,066▼
Other amounts payable178/9€950,234€945,234▼
Amounts payable within one year42/48€590,212€405,777▼
Current portion of amounts payable after more than one year42€121,536€68,152▼
Financial debts43€15,490€15,692▲
Credit institutions430/8€15,490€15,692▲
Trade debts44€263,991€191,509▼
Suppliers440/4€263,991€191,509▼
Taxes, remuneration and social security45€85,007€74,278▼
Taxes450/3€11,965€8,754▼
Remuneration and social security454/9€73,042€65,523▼
Other amounts payable47/48€104,188€56,146▼
Accrued charges and deferred income492/3€26,445€30,573▲
Income statement Code20242025
Remuneration, social security and pensions62€695,746€600,087▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€83,836€81,098▼
Other operating charges640/8€11,628€10,642▼
Gross operating margin9900€811,566€760,921▼
Operating profit (loss)9901€20,356€69,094▲
Financial income75/76B€412€0▼
Recurring financial income75€412€0▼
Financial charges65/66B€25,169€23,441▼
Recurring financial charges65€25,169€23,441▼
Profit (loss) for the period before taxes9903-€4,401€45,654▲
Income taxes67/77€733€270▼
Profit (loss) for the period9904-€5,134€45,384▲
Profit (loss) for the period to be appropriated9905-€5,134€45,384▲
Appropriation of the result
Profit (loss) to be appropriated9906-€160,455-€115,071▲
Profit (loss) brought forward from the previous period14P-€155,321-€160,455▼
Social balance
Average headcount (FTE)90879.78.5▼

The notes to these accounts (17 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Remuneration, social security and pensions62€571,957€619,310€703,054€695,746€600,087▼ 13.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€73,281€76,156€82,561€83,836€81,098▼ 3.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€270€0----
Other operating charges640/8€10,828€10,789€11,102€11,628€10,642▼ 8.5%
Non-recurring operating charges66A€0-----
Gross operating margin9900€887,183€781,748€639,843€811,566€760,921▼ 6.2%
Operating profit (loss)9901€230,849€75,492-€156,874€20,356€69,094▲ 239%
Financial income75/76B€256€36€99€412€0▼ 100%
Recurring financial income75€256€36€99€412€0▼ 100%
Financial charges65/66B€34,763€26,846€27,984€25,169€23,441▼ 6.9%
Recurring financial charges65€34,763€26,846€27,984€25,169€23,441▼ 6.9%
Profit (loss) for the period before taxes9903€196,342€48,683-€184,759-€4,401€45,654▲ 1,137%
Income taxes67/77€28,908€17,121€473€733€270▼ 63.2%
Profit (loss) for the period9904€167,434€31,563-€185,233-€5,134€45,384▲ 984%
Profit (loss) for the period to be appropriated9905€167,434€31,563-€185,233-€5,134€45,384▲ 984%
Line20212022202320242025Change
Assets
Total assets20/58€2.4m€2.1m€1.9m€1.6m€1.4m▼ 12.7%
Fixed assets21/28€1.1m€1.1m€1.1m€983,061€918,899▼ 6.5%
Intangible fixed assets21-€659€343€26€0▼ 100%
Tangible fixed assets22/27€1.1m€1.1m€1.1m€979,263€915,058▼ 6.6%
Land and buildings22€1.1m€1.1m€1.0m€931,777€871,252▼ 6.5%
Plant, machinery and equipment23€61,174€55,477€49,839€44,202€38,565▼ 12.8%
Furniture and vehicles24€1,468€7,363€5,205€3,284€5,242▲ 59.6%
Financial fixed assets28€3,772€3,772€3,772€3,772€3,841▲ 1.8%
Current assets29/58€1.3m€968,254€812,790€650,095€506,180▼ 22.1%
Stocks and contracts in progress3€276,839€304,363€266,082€264,787€281,923▲ 6.5%
Stocks30/36€276,839€304,363€266,082€264,787€281,923▲ 6.5%
Amounts receivable within one year40/41€956,977€621,382€500,245€335,338€179,836▼ 46.4%
Trade receivables40€125,200€120,643€138,220€150,269€137,023▼ 8.8%
Other amounts receivable41€831,777€500,740€362,025€185,068€42,812▼ 76.9%
Cash at bank and in hand54/58€29,623€37,234€29,391€35,031€29,994▼ 14.4%
Deferred charges and accrued income490/1€10,527€5,275€17,072€14,939€14,427▼ 3.4%
Equity and liabilities
Total equity and liabilities10/49€2.4m€2.1m€1.9m€1.6m€1.4m▼ 12.7%
Equity10/15€69,849€101,412-€83,821-€88,955-€43,571▲ 51.0%
Contributions10/11€65,000€65,000€65,000€65,000€65,000=
Capital10€65,000€65,000€65,000€65,000€65,000=
Issued capital100€65,000€65,000€65,000€65,000€65,000=
Reserves13-€6,500€6,500€6,500€6,500=
Non-distributable reserves130/1-€6,500€6,500€6,500€6,500=
Legal reserve130-€6,500€6,500€6,500€6,500=
Profit (loss) carried forward14€4,849€29,912-€155,321-€160,455-€115,071▲ 28.3%
Amounts payable17/49€2.3m€2.0m€2.0m€1.7m€1.5m▼ 14.7%
Amounts payable after more than one year17€1.5m€1.3m€1.2m€1.1m€1.0m▼ 6.6%
Financial debts170/4€540,145€394,270€276,755€155,219€87,066▼ 43.9%
Other amounts payable178/9€950,234€950,234€950,234€950,234€945,234▼ 0.5%
Amounts payable within one year42/48€764,086€570,074€674,562€590,212€405,777▼ 31.2%
Current portion of amounts payable after more than one year42€142,738€145,875€144,900€121,536€68,152▼ 43.9%
Financial debts43€15,000€22,161€18,508€15,490€15,692▲ 1.3%
Credit institutions430/8€15,000€22,161€18,508€15,490€15,692▲ 1.3%
Trade debts44€295,712€302,212€303,186€263,991€191,509▼ 27.5%
Suppliers440/4€295,712€302,212€303,186€263,991€191,509▼ 27.5%
Taxes, remuneration and social security45€71,890€75,405€90,427€85,007€74,278▼ 12.6%
Taxes450/3€9,468€8,855€11,446€11,965€8,754▼ 26.8%
Remuneration and social security454/9€62,422€66,550€78,981€73,042€65,523▼ 10.3%
Other amounts payable47/48€238,747€24,423€117,542€104,188€56,146▼ 46.1%
Accrued charges and deferred income492/3€71,126€77,594€57,782€26,445€30,573▲ 15.6%
Line20212022202320242025Change
Profit (loss) for the period9904€167,434€31,563-€185,233-€5,134€45,384▲ 984%
+ Depreciation and write-downs630€73,281€76,156€82,561€83,836€81,098▼ 3.3%
Operating cash flow (approximation)€240,714€107,719-€102,672€78,702€126,482▲ 60.7%
Investment in fixed assets (approximation)--€80,012-€19,953-€4,175-€16,936▼ 306%
Change in cash-€7,611-€7,844€5,640-€5,036▼ 189%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
20-08
NBB filing Annual accounts filed
fiscal year 2025 · full schema · 20 days late
2025
31-12
Financial Back to profitnet €45,384
Net result €45,384 after 2 loss-making years.
20-05
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
19-08
NBB filing Annual accounts filed
fiscal year 2023 · full schema · 19 days late
2023
25-07
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial Equity above €100,000Eq €101,412 ▲45.2%
4 profitable years in a row build equity to €101,412.
17-08
NBB filing Annual accounts filed
fiscal year 2021 · full schema · 17 days late
2021
31-12
Financial Highest result since 2018net €167,434 ▲529%
Operating result €230,849, net result €167,434, both a record.
01-07
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
28-08
NBB filing Annual accounts filed
fiscal year 2019 · full schema · 28 days late
2019
31-12
Financial Back to profitnet €107,037
Net result €107,037 after one loss-making year.
30-08
NBB filing Annual accounts filed
fiscal year 2018 · full schema · 30 days late
2018
28-09
NBB filing Annual accounts filed
fiscal year 2017 · full schema · 59 days late
2017
11-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 11 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts

We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Arlon · 1 establishment unit since 2011
seat establishment The establishment unit on the map
Ground area
1,944 m²
Building footprint
449 m²
Parcel 81001A1339/00Y000, Wallonia. Linked by address, not a title deed.
4 companies at this address See who is registered here
1 establishment unit
Rue de l'Abattoir 1, 6700 Arlon
Retail sale of pharmaceutical products
since 20112.193.966.487
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
81001A1339/00Y000 Wallonia 1,944 m² 1 · 449 m² -
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 owner

Chain of control

  1. ExpansionPharma 99%
  2. DYNAMIC PHARMA

Highest known parent: ExpansionPharma. The sources do not say who stands above it.

Owners 1

Holdings 0

No holding stated in the accounts, acts or LEI register we read.

According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,422 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded24-11-2010
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:0831334045
Also 9925:BE0831334045
Registered 26-01-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.